Levoketoconazole
Overview
Levoketoconazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL295698).
API suppliers (4)
Suppliers of Levoketoconazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- Torrent PharmaceuticalsIndia1 active DMF GMP on record
- Piramal Pharma LimitedIndia1 active DMF GMP on record
- SS PHARMA LLCIndia1 active DMF
- OLON SPAItaly1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Levoketoconazole expires 2 Mar 2040 and exclusivity 30 Dec 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
- Canonical SMILES
- CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
- InChIKey
- XMAYWYJOQHXEEK-ZEQKJWHPSA-N
Do you supply Levoketoconazole? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.